Curia Italy Srl, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Curia- A partner for the pharma and biotech industries to improve patient outcomes & quality of life.
One of their notable products is ERGOTAMINE TARTRATE USP/EP, with a corresponding US DMF Number 22932.
Remarkably, this DMF maintains an Active status since its submission on July 06, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 16, 2014, and payment made on December 02, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II